S556-0899 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-{4-[5-(methoxymethyl)-1,2,4-oxadiazol-3-yl]phenoxy}azetidine-1-carboxamide

S556-0899 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-{4-[5-(methoxymethyl)-1,2,4-oxadiazol-3-yl]phenoxy}azetidine-1-carboxamide
S556-0899 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-{4-[5-(methoxymethyl)-1,2,4-oxadiazol-3-yl]phenoxy}azetidine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S556-0899
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-{4-[5-(methoxymethyl)-1,2,4-oxadiazol-3-yl]phenoxy}azetidine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S556-0899

Molecular Formula

C22H22N4O6 (C22 H22 N4 O6)

Compound Name

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-{4-[5-(methoxymethyl)-1,2,4-oxadiazol-3-yl]phenoxy}azetidine-1-carboxamide

IUPAC name

N-(23-dihydro-14-benzodioxin-6-yl)-3-{4-[5-(methoxymethyl)-124-oxadiazol-3-yl]phenoxy}azetidine-1-carboxamide

SMILES

COCc1nc(-c(cc2)ccc2OC(C2)CN2C(Nc(cc2)cc3c2OCCO3)=O)no1

InChI

InChI=1S/C22H22N4O6/c1-28-13-20-24-21(25-32-20)14-2-5-16(6-3-14)31-17-11-26(12-17)22(27)23-15-4-7-18-19(10-15)30-9-8-29-18/h2-7,10,17H,8-9,11-13H2,1H3,(H,23,27)

InChI Key

OSSVYVPFXJIGSO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD31991524

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

438.44

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.127

Distribution Coefficient, logD

2.127

Water Solubility, LogSw

-3.06

Polar Surface Area

87.757

Acid Dissociation Constant (pKa)

12.28

Base Dissociation Constant (pKb)

2.97

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.82

S556-0899 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S556-0899 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S556-0899?
Check Price and Availability of S556-0899, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S556-0899 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S556-0899
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S556-0899
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S556-0899 available by request